{
  "id": 20452301,
  "title": "Novo Nordisk Highlights Protective Bone Biomarkers For CagriSema And Pediatric BMI Drops",
  "url": "https://urgent.news/2026/11/17/novo-nordisk-highlights-protective-bone-biomarkers-for-cagrisema-and",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-17T14:49:22.000Z",
  "source": {
    "name": "Benzinga",
    "slug": "benzinga",
    "url": "https://www.benzinga.com/news/health-care/26/11/63342393/novo-nordisk-highlights-protective-bone-biomarkers-for-cagrisema-and-pediatric-bmi-drops"
  },
  "original_language": "en",
  "account": "Novo Nordisk unveiled data at ObesityWeek 2026 showcasing its amylin-based treatments' support for bone health during weight loss, alongside semaglutide's ability to reduce body mass index in obese children. Amylin receptor activation through dual activation of amylin and calcitonin receptors helps maintain bone integrity, as demonstrated by preclinical and clinical studies. In an eight-week study modeling postmenopausal bone loss, cagrilintide and CagriSema preserved trabecular bone volume compared to untreated controls, with femur trabecular bone volume being 43% higher with cagrilintide and 40% higher with CagriSema. In a phase 3 REDEFINE 1 trial, CagriSema maintained normal bone mineral density and increased bone-formation markers despite significant weight loss. Meanwhile, semaglutide alone reduced bone mineral density alongside weight loss. In children aged 6 to 12 with obesity, once-weekly semaglutide injections resulted in a 17.4% mean reduction in BMI after 68 weeks, with 40.4% of adherent children no longer meeting obesity criteria, demonstrating comparable safety to previous trials.",
  "summary": "Novo Nordisk AG (NYSE:NVO) presented new data at ObesityWeek 2026 demonstrating that its investigational amylin-based therapies support bone health during weight loss, while once-weekly semaglutide significantly reduces body mass index in children with obesity . Amylin Pipeline Protects Bone Health Substantial weight loss from medication, surgery, or diet can lower bone mass and increase fracture…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}